Latest Headlines

  1. Nu-Tek BioSciences To Highlight Animal-Origin-Free Peptones, Supply Chain Strength At DCAT Week 2026 2/25/2026

    Nu-Tek BioSciences, the market leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it will participate in the upcoming Drug, Chemical and Associated Technologies (DCAT) Week 2026, hosted March 23–26 in New York City. 

  2. Bora Pharmaceuticals And GSK Sign $250M Five Year Global Manufacturing Contract 2/24/2026

    This renewed collaboration reinforces the long-standing relationship between the two companies and expands the partnership, allowing GSK access to multiple sites within the Bora network, including its newest OSD site in Maple Grove, Minnesota.

  3. Minaris And Genetix Biotherapeutics Expand Manufacturing Partnership To Support Commercial Supply For LYFGENIA™ (lovotibeglogene autotemcel) 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, and Genetix Biotherapeutics Inc., a commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases, today announced an expanded manufacturing partnership to increase commercial-scale production of LYFGENIA, Genetix’s FDA-approved, one-time gene therapy for individuals 12 years and older with sickle cell disease.

  4. Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced an upgrade to its Viral Clearance laboratory capabilities at its Philadelphia campus.

  5. Minaris Joins CIRM Industry Resource Partner Program 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced that it has joined the California Institute for Regenerative Medicine (CIRM) Industry Resource Partner (IRP) Program.

  6. Nucleus Biologics Launches Krakatoa® K500: A Pod-Based, On-Demand Media And Buffer Manufacturing System Transforming Scale Bioproduction 2/13/2026

    Nucleus Biologics announces the launch of Krakatoa® K500, the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand and at point-of-use.

  7. JHS CEO Chris Preti Receives 2026 Person Of Influence Award 2/12/2026

    Spokane, WA. - The Spokane Journal of Business named Chris Preti, CEO of Jubilant HollisterStier (JHS), as one of its 2026 People of Influence.

  8. AGC Biologics Seattle Site Now Certified To Manufacture Biologics For Largest Pharmaceutical Market In South America 2/5/2026

    AGC Biologics’ Seattle site earned Anvisa GMP certification, enabling biologics and biosimilars produced there to enter Brazil’s expanding pharmaceutical market and strengthening the facility’s global regulatory track record.

  9. Eurofins CDMO Alphora Joins International Consortium Project To Advance Next Generation ADC Expression Platform 2/5/2026

    As part of this initiative, Eurofins CDMO Alphora (Canada) is collaborating with Daresbury Proteins Ltd. (UK) to contribute its development and manufacturing expertise to the NextGen ADC Platform: Engineering High Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production initiative.

  10. Kindeva Announces Leadership Transition To Drive Strategic Growth 1/16/2026

    Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery.